Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine

Kidney Cancer Clinical Trials

A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 7 Last 

Arizona

Research Site
Scottsdale Arizona 85259

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tucson Arizona 85724

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Scottsdale Arizona 85258

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale Arizona 85259-5499

A clinical trial to evaluate treatments using hypoxia-activated prodrug TH-302, sorafenib tosylate, protein analysis and laboratory biomarker analysis for patients with Kidney Cancer or Liver Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Arkansas

Research Site
Little Rock Arkansas 72205

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

California

Research Site
La Jolla California 92093-0698

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90024

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90048

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
San Francisco California 94115

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Stanford California 94305-5334

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

La Jolla California 92093

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Los Angeles California 90024

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

UPDATED

Stanford California 94305

A Phase 2 clinical study for patients with Genitourinary Cancer or Kidney Cancer

Colorado

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Colorado Springs Colorado 80909

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Denver Colorado 80211

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Parker Colorado 80134

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Colorado Springs Colorado 80909

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Denver Colorado 80211

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Parker Colorado 80134

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Connecticut

Research Site
Hartford Connecticut 06102-5037

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Hartford Connecticut 06102

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Florida

Research Site
Miami Florida 33140

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tampa Florida 33612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Miami Florida 33140

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Georgia

Research Site
Atlanta Georgia 30322

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Augusta Georgia 30912

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Lenalidomide and Everolimus to evaluate Solid Organ Malignancies

Augusta Georgia 30912

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Idaho

Research Site
Boise Idaho 83706

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Meridian Idaho 83642

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Boise Idaho 83706

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Meridian Idaho 83642

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Illinois

Research Site
Chicago Illinois 60640

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Sherman Health
Elgin Illinois 60123

SWOG S0931 Phase III Randomized Study of Everolimus Versus Placebo in Patients With Renal Cell Carcinoma Who Have Undergone Nephrectomy or Partial Nephrectomy

Research Site
Hines Illinois 60141

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Maywood Illinois 60153

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Skokie Illinois 60076

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Springfield Illinois 62702

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

First 1 2 3 4 5 6 7 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.